Table 1.
Two-Year Experience With FK 506 in Pediatric Patients: Primary Transplants
| Liver* | Kidney (Cadaver) | Kidney (LRD) | Heart | Lung | Liver + Islets | Liver–Small Bowel | Isolated Small Bowel | |
|---|---|---|---|---|---|---|---|---|
| No | 116 | 13 | 7 | 21 | 4 | 2 | 6 | 3 |
| Age | 2 mo–16 y | 3–16 y | 8–17 y | 7 h–18 y | 4–15 y | 8 y, 16 y | 6 mo–3 y | 14 mo–10 y |
| Follow-up: (mo) | 10–34 | 11–32 | 11–23 | 12–33 | 10–12 | 31 | 13–26 | 5–9 |
| Graft survival | 78% | 92% | 100% | 81% | 75% | 50% | 66% | 100% |
| Patient survival | 86% | 100% | 100% | 81% | 75% | 50% | 66% | 100% |
*
One patient recerved simultaneous kidney transplantation but died from hepatic artery thrombosis. One patient developed aplastic anemia after transplantation from fulminant hepatitis and underwent successful bone marrow transplantation.